AOAmanda O'Donnell

Amanda O'Donnell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amanda O'Donnell has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    PARP1 orchestrates variant histone exchange in signal‐mediated transcriptional activation

    by Amanda O'DOnnell, Shen‐Hsi Yang, Andrew D Sharrocks

    Transcriptional activation is accompanied by multiple molecular events that remodel the local chromatin environment in promoter regions. These molecular events are often orchestrated in response to the activation of signalling pathways, as exemplified by the response of immediate early genes such as FOS to ERK MAP kinase signalling. Here, we demonstrate that inducible NFI recruitment permits PARP1 binding to the FOS promoter by a mutually reinforcing loop. PARP1 and its poly(ADP‐ribosyl)ation activity are required for maintaining FOS activation kinetics. We also show that the histone variant H2A.Z associates with the FOS promoter and acts in a transcription‐suppressive manner. However, in response to ERK pathway signalling, H2A.Z is replaced by H2A; PARP1 activity is required to promote this exchange. Thus, our work has revealed an additional facet of PARP1 function in promoting dynamic remodelling of promoter‐associated nucleosomes to allow transcriptional activation in response to cellular signalling.


  • Immediate-early gene activation by the MAPK pathways: what do and don't we know?

    by Amanda O'Donnell, Zaneta Odrowaz, Andrew D. Sharrocks

    The study of IE (immediate-early) gene activation mechanisms has provided numerous paradigms for how transcription is controlled in response to extracellular signalling. Many of the findings have been derived from investigating one of the IE genes, FOS, and the models extrapolated to regulatory mechanisms for other IE genes. However, whereas the overall principles of activation appear similar, recent evidence suggests that the underlying mechanistic details may differ depending on cell type, cellular stimulus and IE gene under investigation. In the present paper, we review recent advances in our understanding of IE gene transcription, chiefly focusing on FOS and its activation by ERK (extracellular-signal-regulated kinase) MAPK (mitogen-activated protein kinase) pathway signalling. We highlight important fundamental regulatory principles, but also illustrate the gaps in our current knowledge and the potential danger in making assumptions based on extrapolation from disparate studies.


  • Open Access

    Overlapping promoter targeting by Elk-1 and other divergent ETS-domain transcription factor family members

    by Joanna Boros, Amanda O’donnell, Ian J. Donaldson, Aneta Kasza, Leo Zeef, Andrew D. Sharrocks

    ETS-domain transcription factors play important roles in controlling gene expression in a variety of different contexts; however, these proteins bind to very similar sites and it is unclear how in vivo specificity is achieved. In silico analysis is unlikely to reveal specific targets for individual family members and direct experimental approaches are therefore required. Here, we take advantage of an inducible dominant-negative expression system to identify a group of novel target genes for the ETS-domain transcription factor Elk-1. Elk-1 is thought to mainly function through cooperation with a second transcription factor SRF, but the targets we identify are largely SRF-independent. Furthermore, we demonstrate that there is a high degree of overlapping, cell type-specific, target gene binding by Elk-1 and other ETS-domain transcription factors. Our results are therefore consistent with the notion that there is a high degree of functional redundancy in target gene regulation by ETS-domain transcription factors in addition to the specific target gene regulation that can be dictated through heterotypic interactions exemplified by the Elk-1-SRF complex.


  • Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery

    by Joanna Boros, Ian J. Donaldson, Amanda O'Donnell, Zaneta A. Odrowaz, Leo Zeef, Mathieu Lupien, Clifford A. Meyer, X. Shirley Liu, Myles Brown, Andrew D. Sharrocks

    Transcription factors play an important role in orchestrating the activation of specific networks of genes through targeting their proximal promoter and distal enhancer regions. However, it is unclear how the specificity of downstream responses is maintained by individual members of transcription-factor families and, in most cases, what their target repertoire is. We have used ChIP-chip analysis to identify the target genes of the ETS-domain transcription factor ELK1. Two distinct modes of ELK1 target gene selection are identified; the first involves redundant promoter binding with other ETS-domain family members; the second occurs through combinatorial binding with a second transcription factor SRF, which specifies a unique group of target genes. One of the most prominent groups of genes forming the ELK1 target network includes classes involved in core gene expression control, namely, components of the basal transcriptional machinery, the spliceosome and the ribosome. Amongst the set of genes encoding the basal transcription machinery components, are a functionally linked subset of GTFs and TAFs. Our study, therefore, reveals an unsuspected level of coordinate regulation of components of the core gene expression control machinery and also identifies two different modes of promoter targeting through binding with a second transcription factor or redundant binding with other ETS-domain family members.


  • Open Access

    MAP Kinase-Mediated c-fos Regulation Relies on a Histone Acetylation Relay Switch

    by Amanda O'DOnnell, Shen-Hsi Yang, Andrew D. Sharrocks


  • Regulation of transcription of the RNA splicing factor hSlu7 by Elk-1 and Sp1 affects alternative splicing

    by Moti Alberstein, Maayan Amit, Keren Vaknin, Amanda O'Donnell, Chen Farhy, Yaniv Lerenthal, Noam Shomron, Ohad Shaham, Andrew D. Sharrocks, Ruth Ashery-Padan, et al.

    Alternative splicing plays a major role in transcriptome diversity and plasticity, but it is largely unknown how tissue-specific and embryogenesis-specific alternative splicing is regulated. The highly conserved splicing factor Slu7 is involved in 3′ splice site selection and also regulates alternative splicing. We show that Slu7 has a unique spatial pattern of expression among human and mouse embryonic and adult tissues. We identified several functional Ets binding sites and GC-boxes in the human Slu7 (hSlu7) promoter region. The Ets and GC-box binding transcription factors, Elk-1 and Sp1, respectively, exerted opposite effects on hSlu7 transcription: Sp1 protein enhances and Elk-1 protein represses transcription in a dose-dependent manner. Sp1 protein bound to the hSlu7 promoter in vivo, and depletion of Sp1 by RNA interference (RNAi) repressed hSlu7 expression. Elk-1 protein bound to the hSlu7 promoter in vivo, and depletion of Elk-1 by RNAi caused an increase in the endogenous level of hSlu7 mRNA. Further, depletion of either Sp1 or Elk-1 affected alternative splicing. Our results provide indications of a complex transcription regulation mechanism that controls the spatial and temporal expression of Slu7, presumably allowing regulation of tissue-specific alternative splicing events.


  • Open Access

    Assembly of transcription factor IIB at a promoter in vivo requires contact with RNA polymerase II

    by Laura M Elsby, Amanda J M O'DOnnell, Laura M Green, Andrew D Sharrocks, Stefan G E Roberts

    EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.


  • Open Access

    14‐3‐3 proteins integrate E2F activity with the DNA damage response

    by Alasdair H Milton, Nandkumar Khaire, Laura Ingram, Amanda J O'DOnnell, Nicholas B La Thangue

    The E2F family is composed of at least eight E2F and two DP subunits, which in cells exist as E2F/DP heterodimers that bind to and regulate E2F target genes. While DP‐1 is an essential and widespread component of E2F, much less is known about the DP‐3 subunit, which exists as a number of distinct protein isoforms that differ in several respects including the presence of a nuclear localisation signal (NLS). We show here that the NLS region of DP‐3 harbours a binding site for 14‐3‐3ε, and that binding of 14‐3‐3ε alters the cell cycle and apoptotic properties of E2F. DP‐3 responds to DNA damage, and the interaction between DP‐3 and 14‐3‐3ε is under DNA damage‐responsive control. Further, 14‐3‐3ε is present in the promoter region of certain E2F target genes, and reducing 14‐3‐3ε levels induces apoptosis. These results identify a new level of control on E2F activity and, at a more general level, suggest that 14‐3‐3 proteins integrate E2F activity with the DNA damage response.


  • Open Access

    The ETS Domain Transcription Factor Elk-1 Regulates the Expression of Its Partner Protein, SRF

    by Aneta Kasza, Amanda O'Donnell, Karen Gascoigne, Leo A. H. Zeef, Andy Hayes, Andrew D. Sharrocks


  • Ternary Complex Factor-Serum Response Factor Complex-Regulated Gene Activity Is Required for Cellular Proliferation and Inhibition of Apoptotic Cell Death

    by Elaine R. Vickers, Aneta Kasza, Isil Aksan Kurnaz, Anne Seifert, Leo A. H. Zeef, Amanda O'Donnell, Andy Hayes, Andrew D. Sharrocks

    Members of the ternary complex factor (TCF) subfamily of the ETS-domain transcription factors are activated through phosphorylation by mitogen-activated protein kinases (MAPKs) in response to a variety of mitogenic and stress stimuli. The TCFs bind and activate serum response elements (SREs) in the promoters of target genes in a ternary complex with a second transcription factor, serum response factor (SRF). The association of TCFs with SREs within immediate-early gene promoters is suggestive of a role for the ternary TCF-SRF complex in promoting cell cycle entry and proliferation in response to mitogenic signaling. Here we have investigated the downstream gene regulatory and phenotypic effects of inhibiting the activity of genes regulated by TCFs by expressing a dominantly acting repressive form of the TCF, Elk-1. Inhibition of ternary complex activity leads to the downregulation of several immediate-early genes. Furthermore, blocking TCF-mediated gene expression leads to growth arrest and triggers apoptosis. By using mutant Elk-1 alleles, we demonstrated that these effects are via an SRF-dependent mechanism. The antiapoptotic gene Mcl-1 is identified as a key target for the TCF-SRF complex in this system. Thus, our data confirm a role for TCF-SRF-regulated gene activity in regulating proliferation and provide further evidence to indicate a role in protecting cells from apoptotic cell death.